1. Home
  2. LPRO vs QNCX Comparison

LPRO vs QNCX Comparison

Compare LPRO & QNCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Open Lending Corporation

LPRO

Open Lending Corporation

HOLD

Current Price

$1.21

Market Cap

142.4M

Sector

Finance

ML Signal

HOLD

Logo Quince Therapeutics Inc.

QNCX

Quince Therapeutics Inc.

HOLD

Current Price

$0.10

Market Cap

167.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LPRO
QNCX
Founded
2000
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
142.4M
167.0M
IPO Year
2020
2019

Fundamental Metrics

Financial Performance
Metric
LPRO
QNCX
Price
$1.21
$0.10
Analyst Decision
Buy
Hold
Analyst Count
6
2
Target Price
$2.46
N/A
AVG Volume (30 Days)
560.5K
17.3M
Earning Date
05-06-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
96.46
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$10.12
N/A
Revenue Next Year
$17.80
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.70
$0.08
52 Week High
$2.70
$4.55

Technical Indicators

Market Signals
Indicator
LPRO
QNCX
Relative Strength Index (RSI) 38.62 30.57
Support Level N/A $0.08
Resistance Level $1.96 $0.98
Average True Range (ATR) 0.10 0.01
MACD -0.00 0.04
Stochastic Oscillator 6.74 46.41

Price Performance

Historical Comparison
LPRO
QNCX

About LPRO Open Lending Corporation

Open Lending Corp is a provider of lending enablement and risk analytics to credit unions, regional banks, finance companies and the captive finance companies of automakers (OEM captive finance companies). Through its flagship product, LPP, its customers, collectively referred to herein as automotive lenders or lenders, make automotive consumer loans to underserved near-prime and non-prime borrowers by harnessing its risk-based interest rate pricing models, powered by its proprietary data and real-time underwriting of automotive loan default insurance coverage from insurers.

About QNCX Quince Therapeutics Inc.

Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.

Share on Social Networks: